Skip to main content
Top
Gepubliceerd in:

28-07-2022

Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men

Auteurs: Maria D. Jackson, Evelyn Walker, Marshall K. Tulloch-Reid

Gepubliceerd in: Quality of Life Research | Uitgave 12/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Prostate cancer (PCa) and its treatment can impact health-related quality of life (HRQoL). There are few studies of HRQoL in long-term PCa survivors of African ancestry from low- and middle-income countries. We examined the effect of PCa treatment on HRQoL of Jamaican PCa survivors compared with cancer-free controls and explored the effect of demographic and clinical factors on these outcomes.

Methods

PCa survivors (n = 64) treated with and without ADT along with PCa-free controls (n = 88) from a case–control study of 10 years post enrolment. HRQoL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life (EORTC-QLQ-C30). Effects of demographic and clinical variables on HRQoL on PCa and type of therapy were evaluated in multivariable linear regression models.

Results

HRQoL of PCa survivors (overall and by treatment group) indicated a high quality of life, comparable to PCa-free men. However, ADT-treated survivors had lower physical functioning that was of small clinical relevance compared with those not on ADT. Symptom burden scores of PCa survivors and controls were similar excluding fatigue and dyspnoea which were highest in men on ADT and controls. In multivariable models, PCa was not an important determinant of overall HRQoL, functioning or symptom burdens. Underlying medical conditions and marital status were the main contributors to HRQoL in PCa survivors.

Conclusion

PCa cancer status was not an independent determinant of long-term HRQoL in Jamaican men. Interventions addressing social factors and comorbid illnesses could improve HRQOL in long-term PCa survivors.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Disease, G. B. D., Injury, I., & Prevalence, C. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392(10159), 1789–1858.CrossRef Disease, G. B. D., Injury, I., & Prevalence, C. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392(10159), 1789–1858.CrossRef
3.
go back to reference Surbone, A., & Tralongo, P. (2016). Categorization of cancer survivors: Why we need it. Journal of Clinical Oncology, 34(28), 3372–3374.PubMedCrossRef Surbone, A., & Tralongo, P. (2016). Categorization of cancer survivors: Why we need it. Journal of Clinical Oncology, 34(28), 3372–3374.PubMedCrossRef
4.
go back to reference Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D’Amico, A. V., Davis, B. J., Dorff, T., Eastham, J. A., Enke, C. A., Farrington, T. A., Higano, C. S., Horwitz, E. M., Hurwitz, M., Ippolito, J. E., Kane, C. J., Kuettel, M. R., Lang, J. M., McKenney, J., Netto, G., Penson, D. F., … Freedman-Cass, D. A. (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(5), 479–505.PubMedCrossRef Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D’Amico, A. V., Davis, B. J., Dorff, T., Eastham, J. A., Enke, C. A., Farrington, T. A., Higano, C. S., Horwitz, E. M., Hurwitz, M., Ippolito, J. E., Kane, C. J., Kuettel, M. R., Lang, J. M., McKenney, J., Netto, G., Penson, D. F., … Freedman-Cass, D. A. (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(5), 479–505.PubMedCrossRef
5.
go back to reference Nguyen, P. L., Je, Y., Schutz, F. A., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011). Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials. JAMA, 306(21), 2359–2366.PubMedCrossRef Nguyen, P. L., Je, Y., Schutz, F. A., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011). Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials. JAMA, 306(21), 2359–2366.PubMedCrossRef
6.
go back to reference Galvao, D. A., Spry, N. A., Taaffe, D. R., Newton, R. U., Stanley, J., Shannon, T., Rowling, C., & Prince, R. (2008). Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU International, 102(1), 44–47.PubMedCrossRef Galvao, D. A., Spry, N. A., Taaffe, D. R., Newton, R. U., Stanley, J., Shannon, T., Rowling, C., & Prince, R. (2008). Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU International, 102(1), 44–47.PubMedCrossRef
7.
go back to reference Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S., & McCaul, K. (2006). Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. European Journal of Cancer, 42(8), 1083–1092.PubMedCrossRef Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S., & McCaul, K. (2006). Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. European Journal of Cancer, 42(8), 1083–1092.PubMedCrossRef
8.
go back to reference Groarke, A., Curtis, R., Skelton, J., & Groarke, J. M. (2020). Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience. PLoS ONE, 15(9), e0239469.PubMedPubMedCentralCrossRef Groarke, A., Curtis, R., Skelton, J., & Groarke, J. M. (2020). Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience. PLoS ONE, 15(9), e0239469.PubMedPubMedCentralCrossRef
9.
go back to reference Wu, H. S., & Harden, J. K. (2015). Symptom burden and quality of life in survivorship: A review of the literature. Cancer Nursing, 38(1), E29-54.PubMedCrossRef Wu, H. S., & Harden, J. K. (2015). Symptom burden and quality of life in survivorship: A review of the literature. Cancer Nursing, 38(1), E29-54.PubMedCrossRef
10.
go back to reference Adam, S., Doege, D., Koch-Gallenkamp, L., Thong, M. S. Y., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer-Sauerland, M., Waldmann, A., Zeissig, S. R., Jansen, L., Rohrmann, S., Brenner, H., & Arndt, V. (2020). Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study. Supportive Care in Cancer, 28(6), 2875–2885.PubMedCrossRef Adam, S., Doege, D., Koch-Gallenkamp, L., Thong, M. S. Y., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer-Sauerland, M., Waldmann, A., Zeissig, S. R., Jansen, L., Rohrmann, S., Brenner, H., & Arndt, V. (2020). Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study. Supportive Care in Cancer, 28(6), 2875–2885.PubMedCrossRef
11.
go back to reference Adam, S., Koch-Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer-Sauerland, M., Waldmann, A., Zeissig, S. R., Rohrmann, S., Brenner, H., & Arndt, V. (2019). Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study. European Journal of Cancer Care, 28(5), e13076.PubMedCrossRef Adam, S., Koch-Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer-Sauerland, M., Waldmann, A., Zeissig, S. R., Rohrmann, S., Brenner, H., & Arndt, V. (2019). Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study. European Journal of Cancer Care, 28(5), e13076.PubMedCrossRef
12.
go back to reference Annunziata, M. A., Muzzatti, B., Flaiban, C., Gipponi, K., Carnaghi, C., Tralongo, P., Caruso, M., Cavina, R., & Tirelli, U. (2018). Long-term quality of life profile in oncology: A comparison between cancer survivors and the general population. Supportive Care in Cancer, 26(2), 651–656.PubMedCrossRef Annunziata, M. A., Muzzatti, B., Flaiban, C., Gipponi, K., Carnaghi, C., Tralongo, P., Caruso, M., Cavina, R., & Tirelli, U. (2018). Long-term quality of life profile in oncology: A comparison between cancer survivors and the general population. Supportive Care in Cancer, 26(2), 651–656.PubMedCrossRef
13.
go back to reference Arndt, V., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Hopfner, S., Waldmann, A., Zeissig, S. R., & Brenner, H. (2017). Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncologica, 56(2), 190–197.PubMedCrossRef Arndt, V., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Hopfner, S., Waldmann, A., Zeissig, S. R., & Brenner, H. (2017). Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncologica, 56(2), 190–197.PubMedCrossRef
14.
go back to reference Doege, D., Thong, M. S. Y., Weisser, L., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., Nennecke, A., Pritzkuleit, R., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2021). Health-related quality of life in very long-term cancer survivors 14–24 Years post-diagnosis compared to population controls: A population-based study. Cancers (Basel), 13(11), 2754.CrossRef Doege, D., Thong, M. S. Y., Weisser, L., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., Nennecke, A., Pritzkuleit, R., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2021). Health-related quality of life in very long-term cancer survivors 14–24 Years post-diagnosis compared to population controls: A population-based study. Cancers (Basel), 13(11), 2754.CrossRef
15.
go back to reference Drummond, F. J., Kinnear, H., O’Leary, E., Donnelly, C., Gavin, A., & Sharp, L. (2015). Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. Journal of Cancer Survivorship, 9(2), 361–372.PubMedCrossRef Drummond, F. J., Kinnear, H., O’Leary, E., Donnelly, C., Gavin, A., & Sharp, L. (2015). Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. Journal of Cancer Survivorship, 9(2), 361–372.PubMedCrossRef
16.
go back to reference Gotze, H., Taubenheim, S., Dietz, A., Lordick, F., & Mehnert, A. (2018). Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. Journal of Cancer Survivorship, 12(5), 712–720.PubMedCrossRef Gotze, H., Taubenheim, S., Dietz, A., Lordick, F., & Mehnert, A. (2018). Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. Journal of Cancer Survivorship, 12(5), 712–720.PubMedCrossRef
17.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef
18.
go back to reference Gandek, B., Sinclair, S. J., Kosinski, M., & Ware, J. E., Jr. (2004). Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financing Review, 25(4), 5–25.PubMedPubMedCentral Gandek, B., Sinclair, S. J., Kosinski, M., & Ware, J. E., Jr. (2004). Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financing Review, 25(4), 5–25.PubMedPubMedCentral
19.
go back to reference Kerleau, C., Guizard, A. V., Daubisse-Marliac, L., Heutte, N., Mercier, M., Grosclaude, P., Joly, F., & French Network of Cancer, R. (2016). Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study. European Journal of Cancer, 63, 143–153.PubMedCrossRef Kerleau, C., Guizard, A. V., Daubisse-Marliac, L., Heutte, N., Mercier, M., Grosclaude, P., Joly, F., & French Network of Cancer, R. (2016). Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study. European Journal of Cancer, 63, 143–153.PubMedCrossRef
20.
go back to reference Mols, F., van de Poll-Franse, L. V., Vingerhoets, A. J., Hendrikx, A., Aaronson, N. K., Houterman, S., Coebergh, J. W., & Essink-Bot, M. L. (2006). Long-term quality of life among Dutch prostate cancer survivors: Results of a population-based study. Cancer, 107(9), 2186–2196.PubMedCrossRef Mols, F., van de Poll-Franse, L. V., Vingerhoets, A. J., Hendrikx, A., Aaronson, N. K., Houterman, S., Coebergh, J. W., & Essink-Bot, M. L. (2006). Long-term quality of life among Dutch prostate cancer survivors: Results of a population-based study. Cancer, 107(9), 2186–2196.PubMedCrossRef
21.
go back to reference Jackson, M. D., Walker, S. P., Simpson, C. M., McFarlane-Anderson, N., Bennett, F. I., Coard, K. C., Aiken, W. D., Tulloch, T., Paul, T. J., & Wan, R. L. (2010). Body size and risk of prostate cancer in Jamaican men. Cancer Causes and Control, 21(6), 909–917.PubMedCrossRef Jackson, M. D., Walker, S. P., Simpson, C. M., McFarlane-Anderson, N., Bennett, F. I., Coard, K. C., Aiken, W. D., Tulloch, T., Paul, T. J., & Wan, R. L. (2010). Body size and risk of prostate cancer in Jamaican men. Cancer Causes and Control, 21(6), 909–917.PubMedCrossRef
22.
go back to reference Gleason, D. F., & Mellinger, G. T. (1974). Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. Journal of Urology, 111(1), 58–64.PubMedCrossRef Gleason, D. F., & Mellinger, G. T. (1974). Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. Journal of Urology, 111(1), 58–64.PubMedCrossRef
23.
go back to reference Jackson, M. D., Tulloch-Reid, M. K., McCaw-Binns, A. M., Aiken, W., Ferguson, T. S., Bennett, N. R., Harrison, L., Badaloo, A., McGrowder, D., Grindley, A., Walker, E., & Anderson, S. G. (2020). Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study. Cancer Causes and Control, 31(7), 651–662.PubMedCrossRef Jackson, M. D., Tulloch-Reid, M. K., McCaw-Binns, A. M., Aiken, W., Ferguson, T. S., Bennett, N. R., Harrison, L., Badaloo, A., McGrowder, D., Grindley, A., Walker, E., & Anderson, S. G. (2020). Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study. Cancer Causes and Control, 31(7), 651–662.PubMedCrossRef
24.
go back to reference WHO. (2000). Obesity: Preventing and managing the global epidemic. WHO. (2000). Obesity: Preventing and managing the global epidemic.
25.
go back to reference Cocks, K., King, M. T., Velikova, G., de Castro Jr., G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.PubMedCrossRef Cocks, K., King, M. T., Velikova, G., de Castro Jr., G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.PubMedCrossRef
26.
go back to reference Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMedCrossRef Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMedCrossRef
27.
go back to reference Blank, T. O., & Bellizzi, K. M. (2006). After prostate cancer: Predictors of well-being among long-term prostate cancer survivors. Cancer, 106(10), 2128–2135.PubMedCrossRef Blank, T. O., & Bellizzi, K. M. (2006). After prostate cancer: Predictors of well-being among long-term prostate cancer survivors. Cancer, 106(10), 2128–2135.PubMedCrossRef
28.
go back to reference Walker, R., Szanton, S. L., & Wenzel, J. (2015). Working toward normalcy post-treatment: A qualitative study of older adult breast and prostate cancer survivors. Oncology Nursing Forum, 42(6), E358-367.PubMedPubMedCentralCrossRef Walker, R., Szanton, S. L., & Wenzel, J. (2015). Working toward normalcy post-treatment: A qualitative study of older adult breast and prostate cancer survivors. Oncology Nursing Forum, 42(6), E358-367.PubMedPubMedCentralCrossRef
29.
go back to reference Bellizzi, K. M. (2004). Expressions of generativity and posttraumatic growth in adult cancer survivors. International Journal of Aging and Human Development, 58(4), 267–287.PubMedCrossRef Bellizzi, K. M. (2004). Expressions of generativity and posttraumatic growth in adult cancer survivors. International Journal of Aging and Human Development, 58(4), 267–287.PubMedCrossRef
30.
go back to reference Leach, C. R., Weaver, K. E., Aziz, N. M., Alfano, C. M., Bellizzi, K. M., Kent, E. E., Forsythe, L. P., & Rowland, J. H. (2015). The complex health profile of long-term cancer survivors: Prevalence and predictors of comorbid conditions. Journal of Cancer Survivorship, 9(2), 239–251.PubMedCrossRef Leach, C. R., Weaver, K. E., Aziz, N. M., Alfano, C. M., Bellizzi, K. M., Kent, E. E., Forsythe, L. P., & Rowland, J. H. (2015). The complex health profile of long-term cancer survivors: Prevalence and predictors of comorbid conditions. Journal of Cancer Survivorship, 9(2), 239–251.PubMedCrossRef
31.
go back to reference Luo, Y. H., Yang, Y. W., Wu, C. F., Wang, C., Li, W. J., & Zhang, H. C. (2021). Fatigue prevalence in men treated for prostate cancer: A systematic review and meta-analysis. World Journal of Clinical Cases, 9(21), 5932–5942.PubMedPubMedCentralCrossRef Luo, Y. H., Yang, Y. W., Wu, C. F., Wang, C., Li, W. J., & Zhang, H. C. (2021). Fatigue prevalence in men treated for prostate cancer: A systematic review and meta-analysis. World Journal of Clinical Cases, 9(21), 5932–5942.PubMedPubMedCentralCrossRef
32.
go back to reference Yates, P., Miaskowski, C., Cataldo, J. K., Paul, S. M., Cooper, B. A., Alexander, K., Aouizerat, B., Dunn, L., Ritchie, C., McCarthy, A., & Skerman, H. (2015). Differences in composition of symptom clusters between older and younger oncology patients. Journal of Pain and Symptom Management, 49(6), 1025–1034.PubMedCrossRef Yates, P., Miaskowski, C., Cataldo, J. K., Paul, S. M., Cooper, B. A., Alexander, K., Aouizerat, B., Dunn, L., Ritchie, C., McCarthy, A., & Skerman, H. (2015). Differences in composition of symptom clusters between older and younger oncology patients. Journal of Pain and Symptom Management, 49(6), 1025–1034.PubMedCrossRef
33.
go back to reference Savard, J., Hervouet, S., & Ivers, H. (2013). Prostate cancer treatments and their side effects are associated with increased insomnia. Psycho-Oncology, 22(6), 1381–1388.PubMedCrossRef Savard, J., Hervouet, S., & Ivers, H. (2013). Prostate cancer treatments and their side effects are associated with increased insomnia. Psycho-Oncology, 22(6), 1381–1388.PubMedCrossRef
34.
go back to reference Feng, L. R., Fuss, T., Dickinson, K., Ross, A., & Saligan, L. N. (2019). Co-occurring symptoms contribute to persistent fatigue in prostate cancer. Oncology, 96(4), 183–191.PubMedCrossRef Feng, L. R., Fuss, T., Dickinson, K., Ross, A., & Saligan, L. N. (2019). Co-occurring symptoms contribute to persistent fatigue in prostate cancer. Oncology, 96(4), 183–191.PubMedCrossRef
35.
go back to reference Sammarco, A. (2009). Quality of life of breast cancer survivors: A comparative study of age cohorts. Cancer Nursing, 32(5), 347–356.PubMedCrossRef Sammarco, A. (2009). Quality of life of breast cancer survivors: A comparative study of age cohorts. Cancer Nursing, 32(5), 347–356.PubMedCrossRef
36.
go back to reference Forsythe, L. P., Alfano, C. M., Kent, E. E., Weaver, K. E., Bellizzi, K., Arora, N., Aziz, N., Keel, G., & Rowland, J. H. (2014). Social support, self-efficacy for decision-making, and follow-up care use in long-term cancer survivors. Psycho-Oncology, 23(7), 788–796.PubMedPubMedCentralCrossRef Forsythe, L. P., Alfano, C. M., Kent, E. E., Weaver, K. E., Bellizzi, K., Arora, N., Aziz, N., Keel, G., & Rowland, J. H. (2014). Social support, self-efficacy for decision-making, and follow-up care use in long-term cancer survivors. Psycho-Oncology, 23(7), 788–796.PubMedPubMedCentralCrossRef
37.
go back to reference Nguyen, P. L., Alibhai, S. M., Basaria, S., D’Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European Urology, 67(5), 825–836.PubMedCrossRef Nguyen, P. L., Alibhai, S. M., Basaria, S., D’Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European Urology, 67(5), 825–836.PubMedCrossRef
38.
go back to reference Brundage, M., Sydes, M. R., Parulekar, W. R., Warde, P., Cowan, R., Bezjak, A., Kirkbride, P., Parliament, M., Moynihan, C., Bahary, J. P., Parmar, M. K., Sanders, K., Chen, B. E., & Mason, M. D. (2015). Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer: Long-term quality-of-life outcomes from the NCIC CTG PR3/MRC PR07 Randomized Trial. Journal of Clinical Oncology, 33(19), 2151–2157.PubMedPubMedCentralCrossRef Brundage, M., Sydes, M. R., Parulekar, W. R., Warde, P., Cowan, R., Bezjak, A., Kirkbride, P., Parliament, M., Moynihan, C., Bahary, J. P., Parmar, M. K., Sanders, K., Chen, B. E., & Mason, M. D. (2015). Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer: Long-term quality-of-life outcomes from the NCIC CTG PR3/MRC PR07 Randomized Trial. Journal of Clinical Oncology, 33(19), 2151–2157.PubMedPubMedCentralCrossRef
39.
go back to reference Moul, J. W., & Dawson, N. (2012). Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature. Cancer Investigation, 30(1), 1–12.PubMedCrossRef Moul, J. W., & Dawson, N. (2012). Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature. Cancer Investigation, 30(1), 1–12.PubMedCrossRef
40.
go back to reference Geerkens, M. J. M., Pouwels, N. S. A., & Beerlage, H. P. (2020). The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: A systematic review. Quality of Life Research, 29(4), 843–865.PubMedCrossRef Geerkens, M. J. M., Pouwels, N. S. A., & Beerlage, H. P. (2020). The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: A systematic review. Quality of Life Research, 29(4), 843–865.PubMedCrossRef
41.
go back to reference Adam, S., Thong, M. S. Y., Martin-Diener, E., Camey, B., Egger Hayoz, C., Konzelmann, I., Mousavi, S. M., Herrmann, C., Rohrmann, S., Wanner, M., Staehelin, K., Strebel, R. T., Randazzo, M., John, H., Schmid, H. P., Feller, A., & Arndt, V. (2021). Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS). Supportive Care in Cancer, 29(11), 6259–6269.PubMedPubMedCentralCrossRef Adam, S., Thong, M. S. Y., Martin-Diener, E., Camey, B., Egger Hayoz, C., Konzelmann, I., Mousavi, S. M., Herrmann, C., Rohrmann, S., Wanner, M., Staehelin, K., Strebel, R. T., Randazzo, M., John, H., Schmid, H. P., Feller, A., & Arndt, V. (2021). Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS). Supportive Care in Cancer, 29(11), 6259–6269.PubMedPubMedCentralCrossRef
42.
go back to reference Pearson, E. J. M., Morris, M. E., di Stefano, M., & McKinstry, C. E. (2018). Interventions for cancer-related fatigue: a scoping review. European Journal of Cancer Care (Engl), 27(1), e12516.CrossRef Pearson, E. J. M., Morris, M. E., di Stefano, M., & McKinstry, C. E. (2018). Interventions for cancer-related fatigue: a scoping review. European Journal of Cancer Care (Engl), 27(1), e12516.CrossRef
43.
go back to reference Kim, M. S., Jung, S. I., Chung, H. S., Chang Hwang, E., & Kwon, D. (2021). Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study. Prostate International, 9(3), 132–139.PubMedCrossRef Kim, M. S., Jung, S. I., Chung, H. S., Chang Hwang, E., & Kwon, D. (2021). Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study. Prostate International, 9(3), 132–139.PubMedCrossRef
44.
go back to reference Gordon, L. G., Merollini, K. M. D., Lowe, A., & Chan, R. J. (2017). A Systematic review of financial toxicity among cancer survivors: We can’t pay the co-pay. Patient, 10(3), 295–309.PubMedCrossRef Gordon, L. G., Merollini, K. M. D., Lowe, A., & Chan, R. J. (2017). A Systematic review of financial toxicity among cancer survivors: We can’t pay the co-pay. Patient, 10(3), 295–309.PubMedCrossRef
45.
go back to reference Pearce, A., Tomalin, B., Kaambwa, B., Horevoorts, N., Duijts, S., Mols, F., van de Poll-Franse, L., & Koczwara, B. (2019). Financial toxicity is more than costs of care: The relationship between employment and financial toxicity in long-term cancer survivors. Journal of Cancer Survivorship, 13(1), 10–20.PubMedCrossRef Pearce, A., Tomalin, B., Kaambwa, B., Horevoorts, N., Duijts, S., Mols, F., van de Poll-Franse, L., & Koczwara, B. (2019). Financial toxicity is more than costs of care: The relationship between employment and financial toxicity in long-term cancer survivors. Journal of Cancer Survivorship, 13(1), 10–20.PubMedCrossRef
46.
go back to reference van Andel, G., Bottomley, A., Fossa, S. D., Efficace, F., Coens, C., Guerif, S., Kynaston, H., Gontero, P., Thalmann, G., Akdas, A., D’Haese, S., & Aaronson, N. K. (2008). An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. European Journal of Cancer, 44(16), 2418–2424.PubMedCrossRef van Andel, G., Bottomley, A., Fossa, S. D., Efficace, F., Coens, C., Guerif, S., Kynaston, H., Gontero, P., Thalmann, G., Akdas, A., D’Haese, S., & Aaronson, N. K. (2008). An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. European Journal of Cancer, 44(16), 2418–2424.PubMedCrossRef
Metagegevens
Titel
Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men
Auteurs
Maria D. Jackson
Evelyn Walker
Marshall K. Tulloch-Reid
Publicatiedatum
28-07-2022
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 12/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03202-2